Rheumatoid Arthritis Drugs Market Size– By Drug Class Type, By Route of Administration, By Sales Channel, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $4,250	234 Pages	SPER Market Research Pvt. Ltd.	April, 2024	SPER19034300

Best Price Guarantee
Price	from $4,250
Length	234 Pages
Publisher	SPER Market Research Pvt. Ltd.
Published Date	April, 2024
SKU	SPER19034300

Rheumatoid Arthritis Drugs Market Introduction and Overview

According to SPER market research, Rheumatoid Arthritis Drugs Market Size– By Drug Class Type, By Route of Administration, By Sales Channel, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033 state that the Global Rheumatoid Arthritis Drugs Market is predicted to reach 78718.42 million by 2033 with a CAGR of 3.8%.

Rheumatoid arthritis is an autoimmune disease that results in the body’s immune system attacking its own tissues, including joints. This leads to edema and painful joint stiffness. A medication used to treat rheumatoid arthritis is known as an anti-rheumatic medication. All ages are affected by this ailment, albeit the elderly are most susceptible to it. Rheumatoid arthritis symptoms include swelling, stiffness, pain, and discomfort in the joints. Rheumatoid arthritis currently has no recognized treatment.

On January 30, 2020, the World Health Organization (WHO) deemed the COVID-19 pandemic a global public health emergency. Globally, COVID-19 has had an impact on around 210 countries. Patients with rheumatoid arthritis who also have COVID-19 infection may be more likely to experience severe symptoms and other problems, according to the Lancet Rheumatology 2020. Certain DMARDs, such hydroxychloroquine, are being studied as possible COVID-19 therapies in addition to being often used to treat rheumatoid arthritis.

Scope of the Report:

Report Metric Details

Market size available for years 2020-2033

Base year considered 2023

Forecast period 2024-2033

Segments covered By Drug Class Type, By Route of Administration, By Sales Channel, By Distribution Channel

Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe

Companies Covered

AbbVie Inc, Johnson & Johnson Innovative Medicine, Amgen Inc, Pfizer Inc, Novartis AG, Sanofi S.A, F. Hoffmann-La Roche Ltd, Merck & Co, Inc, Bristol-Myers Squibb Company, and Eli Lilly and Company.

Rheumatoid Arthritis Drugs Market Segmentation

By Drug Class Type: Based on the Drug Class Type, Global Rheumatoid Arthritis Drugs Market is segmented as, Disease-modifying Anti-Rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, Others.

By Route of Administration: Based on the Route of Administration, Global Rheumatoid Arthritis Drugs Market is segmented as; Oral, Parenteral.

By Sales Channel: Based on the Sales Channel, Global Rheumatoid Arthritis Drugs Market is segmented as; Prescription-based Drugs, Over-the-counter Drugs.

By Distribution Channel:Based on the Distribution Channel, Global Rheumatoid Arthritis Drugs Market is segmented as; Hospital Pharmacy, Retail Pharmacy, Online Pharmacy.

1. Introduction: 1.1. Scope of the report; 1.2. Market segment analysis
2. Research Methodology: 2.1. Research data source; 2.1.1. Secondary Data; 2.1.2. Primary Data; 2.1.3. SPER’s internal database; 2.1.4. Premium insight from KOL’s; 2.2. Market size estimation; 2.2.1. Top-down and Bottom-up approach; 2.3. Data triangulation
3. Executive Summary
4. Market Dynamics: 4.1. Driver, Restraint, Opportunity and Challenges analysis; 4.1.1. Drivers; 4.1.2. Restraints; 4.1.3. Opportunities; 4.1.4. Challenges; 4.2. COVID-19 Impacts of the Global Rheumatoid Arthritis Drugs Market
5. Market variable and outlook: 5.1. SWOT Analysis; 5.1.1. Strengths; 5.1.2. Weaknesses; 5.1.3. Opportunities; 5.1.4. Threats; 5.2. PESTEL Analysis; 5.2.1. Political Landscape; 5.2.2. Economic Landscape; 5.2.3. Social Landscape; 5.2.4. Technological Landscape; 5.2.5. Environmental Landscape; 5.2.6. Legal Landscape; 5.3. PORTER’s Five Forces; 5.3.1. Bargaining power of suppliers; 5.3.2. Bargaining power of buyers; 5.3.3. Threat of Substitute; 5.3.4. Threat of new entrant; 5.3.5. Competitive rivalry; 5.4. Heat Map Analysis
6. Competitive Landscape: 6.1. Global Rheumatoid Arthritis Drugs Market Manufacturing Base Distribution, Sales Area, Ingredients; 6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Rheumatoid Arthritis Drugs Market
7. Global Rheumatoid Arthritis Drugs Market, By Drug Class Type (USD Million) 2020-2033: 7.1. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Drug Class Type, 2020-2026; 7.2. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Drug Class Type, 2027-2033; 7.3. Disease-modifying Anti-Rheumatic Drugs (DMARDs); 7.4. Nonsteroidal Anti-inflammatory Drugs (NSAIDs); 7.5. Corticosteroids; 7.6. Uric Acid Drugs; 7.7. Others
8. Global Rheumatoid Arthritis Drugs Market, By Route of Administration (USD Million) 2020-2033: 8.1. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Route of Administration, 2020-2026; 8.2. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Route of Administration, 2027-2033; 8.3. Oral; 8.4. Parenteral
9. Global Rheumatoid Arthritis Drugs Market, By Sales Channel (USD Million) 2020-2033: 9.1. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Sales Channel, 2020-2026; 9.2. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Sales Channel, 2027-2033; 9.3. Prescription-based Drugs; 9.4. Over-the-counter Drugs
10. Global Rheumatoid Arthritis Drugs Market, By Distribution Channel (USD Million) 2020-2033: 10.1. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Distribution Channel, 2020-2026; 10.2. Global Rheumatoid Arthritis Drugs Market Size, Share and Forecast, By Distribution Channel, 2027-2033; 10.3. Hospital Pharmacy; 10.4. Retail Pharmacy; 10.5. Online Pharmacy
11. Global Rheumatoid Arthritis Drugs Market, Forecast, 2020-2033 (USD Million): 11.1. Global Rheumatoid Arthritis Drugs Market Size and Market Share
12. Global Rheumatoid Arthritis Drugs Market, By Region, 2020-2033 (USD Million): 12.1. Global Rheumatoid Arthritis Drugs Market Size and Market Share, By Region (2020-2026); 12.2. Global Rheumatoid Arthritis Drugs Market Size and Market Share, By Region (2027-2033); 12.3. Asia-Pacific; 12.3.1. Australia; 12.3.2. China; 12.3.3. India; 12.3.4. Japan; 12.3.5. South Korea; 12.3.6. Rest of Asia-Pacific; 12.4. Europe; 12.4.1. France; 12.4.2. Germany; 12.4.3. Italy; 12.4.4. Spain; 12.4.5. United Kingdom; 12.4.6. Rest of Europe; 12.5. Middle East and Africa; 12.5.1. Kingdom of Saudi Arabia; 12.5.2. United Arab Emirates; 12.5.3. Qatar; 12.5.4. South Africa; 12.5.5. Egypt; 12.5.6. Morocco; 12.5.7. Nigeria; 12.5.8. Rest of Middle-East and Africa; 12.6. North America; 12.6.1. Canada; 12.6.2. Mexico; 12.6.3. United States; 12.7. Latin America; 12.7.1. Argentina; 12.7.2. Brazil; 12.7.3. Rest of Latin America
13. Company Profile: 13.1. AbbVie Inc.; 13.1.1. Company details; 13.1.2. Financial outlook; 13.1.3. Product summary; 13.1.4. Recent developments; 13.2. Johnson & Johnson Innovative Medicine; 13.2.1. Company details; 13.2.2. Financial outlook; 13.2.3. Product summary; 13.2.4. Recent developments; 13.3. Amgen Inc.; 13.3.1. Company details; 13.3.2. Financial outlook; 13.3.3. Product summary; 13.3.4. Recent developments; 13.4. Pfizer Inc.; 13.4.1. Company details; 13.4.2. Financial outlook; 13.4.3. Product summary; 13.4.4. Recent developments; 13.5. Novartis AG; 13.5.1. Company details; 13.5.2. Financial outlook; 13.5.3. Product summary; 13.5.4. Recent developments; 13.6. Sanofi S.A.; 13.6.1. Company details; 13.6.2. Financial outlook; 13.6.3. Product summary; 13.6.4. Recent developments; 13.7. F. Hoffmann-La Roche Ltd.; 13.7.1. Company details; 13.7.2. Financial outlook; 13.7.3. Product summary; 13.7.4. Recent developments; 13.8. Merck & Co., Inc.; 13.8.1. Company details; 13.8.2. Financial outlook; 13.8.3. Product summary; 13.8.4. Recent developments; 13.9. Bristol-Myers Squibb Company; 13.9.1. Company details; 13.9.2. Financial outlook; 13.9.3. Product summary; 13.9.4. Recent developments; 13.10. Eli Lilly and Company; 13.10.1. Company details; 13.10.2. Financial outlook; 13.10.3. Product summary; 13.10.4. Recent developments; 13.11. Others
14. List of Abbreviations
15. Reference Links
16. Conclusion
17. Research Scope

Methotrexate Drugs Market - By Indication (Psoriasis, Cancer, Rheumatoid Arthritis), Drug Type (Branded, Generic), Drug Form (Tablet, Liquid, Injectable), Route of Administration (Oral, Subcutaneous), Distribution Channel– Global Forecast (2024 – 2032)

June, 2024 | Published by: Global Market Insights | USD $4,850
Vulvovaginal Candidiasis Treatment Market Size - By Drug Class, By Route of Administration, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecast to 2032

December, 2022 | Published by: SPER Market Research Pvt. Ltd. | USD $4,250
Rheumatoid Arthritis Drugs Market by Drug Class (Disease-modifying Anti-rheumatic Drugs, Nonsteroidal Anti-inflammatory Drugs, Corticosteroids, Uric Acid Drugs, and Others), Route of Administration (Oral and Parenteral), and Sales Channel (Prescription-based Drugs, and Over-the-counter Drugs): Global Opportunity Analysis and Industry Forecast, 2027

July, 2023 | Published by: IHR Insights Pvt Limited | USD $4,500
HIV Drugs Market Size - By Drug Class, By Administration, By Distribution Channel - Regional Outlook, Competitive Strategies and Segment Forecasts to 2032

December, 2022 | Published by: SPER Market Research Pvt. Ltd. | USD $4,250
Canine Arthritis Treatment Market Forecasts to 2030 – Global Analysis By Type (Osteoarthritis, Rheumatoid Arthritis and Juvenile Idiopathic Arthritis), By Treatment Type (Nonsteroidal Anti-Inflammatory Drugs (NSAIDs), Disease-Modifying Antirheumatic Drugs (DMARDs) and Other Treatment Types), Route of Administration, Distribution Channel and By Geography

April, 2024 | Published by: Stratistics Market Research Consulting | USD $4,150
Psoriatic Arthritis Market Share, Size, Trends, Industry Analysis Report, By Route of Administration (Oral, Parenteral, Topical); By Drugs Class; By Distribution Channel; By Region; Segment Forecast, 2022 - 2030

October, 2022 | Published by: Polaris Market Research & Consulting LLP | USD $4,250

PDF E-mail From Publisher:	$4,250
Global Site License Fulfilled by Publisher:	$7,450

Rheumatoid Arthritis Drugs Market Size– By Drug Class Type, By Route of Administration, By Sales Channel, By Distribution Channel- Regional Outlook, Competitive Strategies and Segment Forecast to 2033